Anitox

Biotechnology

United States, Georgia

$50M to $100M

51-200

OncoMed Pharmaceuticals

Biotechnology

United States, California

$50M to $100M

51-200

AVEO Oncology

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Ecovative - the mycelium technology company

Biotechnology

United States, New York

$50M to $100M

51-200

Jounce Therapeutics

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Asuragen

Biotechnology

United States, Texas

$50M to $100M

51-200

Facet Biotech

Biotechnology

United States, Illinois

$50M to $100M

51-200

Prometheus Biosciences

Biotechnology

United States, California

$50M to $100M

51-200

Polysciences

Biotechnology

United States, Pennsylvania

$50M to $100M

51-200

Agrinos

Biotechnology

United States, California

$50M to $100M

51-200

M2S

Biotechnology

United States, New Hampshire

$50M to $100M

51-200

Eurofins DiscoverX

Biotechnology

United States, California

$50M to $100M

51-200

Biocom California

Biotechnology

United States, California

$50M to $100M

51-200

Rules-Based Medicine a Q² Solutions Company

Biotechnology

United States, Texas

$50M to $100M

51-200

Trudeau Institute

Biotechnology

United States, New York

$50M to $100M

51-200

Melinta Therapeutics

Biotechnology

United States, New Jersey

$50M to $100M

51-200

Diatherix

Biotechnology

United States, Alabama

$50M to $100M

51-200

Interpace Biosciences

Biotechnology

United States, New Jersey

$50M to $100M

51-200

AnaSpec

Biotechnology

United States, California

$50M to $100M

51-200

Praxis Precision Medicines

Biotechnology

United States, Massachusetts

$50M to $100M

51-200